Assist Prof Dr khadijeh dizajiasl | Microbiology Award | Outstanding Scientist Award
Assist Prof Dr khadijeh dizajiasl, azad university of tabriz , Iran
Khadijeh Dizaji Asl is an Assistant Professor at Azad University of Medical Sciences, Tabriz. Born on November 2, 1983, in Tabriz, Iran, she holds a B.Sc. in Radiology, an M.Sc., and a Ph.D. in Anatomical Sciences from Tabriz University of Medical Sciences. Her research focuses on NK cell therapy in leukemia and the impact of telomerase inhibition on cancer cells. Khadijeh has authored several impactful publications in renowned journals and has received recognition as an Outstanding PhD student. She is also noted for her teaching in anatomy and histology. π§¬
Publication Profile
Education
Khadijeh Dizaji Asl pursued a diverse academic journey at Tabriz University of Medical Sciences in Iran, beginning with a B.Sc. in Radiology from 2011 to 2013. She then continued her studies with an M.Sc. in Anatomical Sciences from 2014 to 2016, followed by a Ph.D. in the same field from 2016 to 2022. Her educational path reflects a deep commitment to advancing her expertise in medical sciences, particularly in anatomical research and its applications. Throughout her studies, Khadijeh has demonstrated a passion for knowledge and a dedication to contributing significantly to her field. π
Experience: πΌ
π Khadijeh Dizaji Asl is a dedicated educator and researcher specializing in Anatomy and Histopathology. She began her teaching career at Tabriz University of Medical Sciences from 2019 to 2021, instructing courses in Gross Anatomy, Embryology, Histology for Midwives, Operating Room students, and Neuroanatomy for Dentistry students. Currently serving at Islamic Azad University, Tabriz branch, she continues to impart knowledge in Anatomy, Histology, and Embryology since 2021. Additionally, Khadijeh holds the roles of Assistant Professor and Head of the Anatomy and Histopathology Department at Islamic Azad University, Tabriz branch, where she shapes the future of medical education through her expertise and leadership. π
Awards and Honors: π
Khadijeh Dizaji Asl is a distinguished academic and researcher, recognized for her outstanding achievements in the field of anatomical sciences. She earned accolades such as being named the Outstanding PhD student in 2020 and the Educational Outstanding Student during her Masterβs studies in 2016. Her contributions are further underscored by her paper being among the top downloads on Wiley. Currently an Assistant Professor and Head of the Anatomy and Histopathology Department at Islamic Azad University, Tabriz branch, Khadijeh continues to excel in both teaching and advancing scientific knowledge in her specialized field. π§¬
Research Focus
Khadijeh Dizaji Aslβs research primarily revolves around immunotherapy and cellular mechanisms in cancer treatment, focusing specifically on Natural Killer (NK) cells and their application in acute myeloid leukemia (AML), leukemia cell lines, and other malignancies. Her studies explore innovative approaches such as CAR-NK cell therapy and the effects of telomerase inhibition on NK cell activity. She investigates the role of KIR-positive NK cells in disease progression and therapeutic interventions. Additionally, Khadijeh explores the impact of NK cell dysfunction in infectious diseases like SARS-CoV-2. Her research aims to advance understanding and improve clinical outcomes through targeted immunotherapies. π§¬
Publications Top Notes
Therapeutic potential of neurotrophic factors in Alzheimerβs Disease Cited by 27, 2022 π
Comparison of characteristics of human amniotic membrane and human adipose tissue derived mesenchymal stem cells Cited by 27, 2017 π
Effect of aberrant DNA methylation on cancer stem cell properties Cited by 25, 2022 π
The role of KIR positive NK cells in diseases and its importance in clinical intervention Cited by 24, 2021 π
Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways Cited by 23, 2022 π
Telomeraseβbased therapies in haematological malignancies Cited by 9, 2022 π
A combination of telomerase inhibition and NK cell therapy increased breast cancer cell line apoptosis Cited by 7, 2023 π
The effect of telomerase inhibition on NK cell activity in acute myeloid leukemia Cited by 7, 2023 π
NK cell dysfunction is linked with disease severity in SARSβCoVβ2 patients Cited by 7, 2022 π
Bone marrow CD34 positive cells may be suitable for collection after death Cited by 3, 2022 π
Inhibition of mitochondria induces apoptosis and reduces telomere length and activity in acute myeloid leukemia stem cells